Caricamento...
Integrating Clinical Phenotype and Gene Expression Data to Prioritize Novel Drug Uses
Drug repositioning has been based largely on genomic signatures of drugs and diseases. One challenge in these efforts lies in connecting the molecular signatures of drugs into clinical responses, including therapeutic and side effects, to the repurpose of drugs. We addressed this challenge by evalua...
Salvato in:
| Pubblicato in: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5192994/ https://ncbi.nlm.nih.gov/pubmed/27860440 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12108 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|